Genovis AB (publ.) (STO: GENO)
Sweden
· Delayed Price · Currency is SEK 25.00
-0.45 (-1.77%)
Oct 4, 2024, 5:29 PM CET
Genovis AB (publ.) Market Cap
Genovis AB (publ.) has a market cap or net worth of 1.64 billion as of October 4, 2024. Its market cap has decreased by -48.35% in one year.
Market Cap
1.64B
Enterprise Value
1.58B
Revenue
127.86M
Ranking
n/a
PE Ratio
94.88
Stock Price
25.00
Market Cap Chart
Since April 18, 2008, Genovis AB (publ.)'s market cap has increased from 7.51M to 1.64B, an increase of 21,682.61%. That is a compound annual growth rate of 38.65%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,475.34B |
| Swedish Orphan Biovitrum AB (publ) | 104.27B |
| Getinge AB (publ) | 58.75B |
| Sectra AB (publ) | 54.52B |
| Camurus AB (publ) | 38.78B |
| Vitrolife AB (publ) | 31.76B |
| Medicover AB (publ) | 27.66B |
| Elekta AB (publ) | 27.03B |